Cargando…
Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine
Nanoparticles (NPs) have shown promise in both radiotherapy and chemotherapy. NPs are mainly transported along cellular microtubules (MTs). Docetaxel (DTX) is a commonly used chemotherapeutic drug that can manipulate the cellular MT network to maximize its clinical benefit. However, the effect of DT...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355834/ https://www.ncbi.nlm.nih.gov/pubmed/32545909 http://dx.doi.org/10.3390/bioengineering7020056 |
_version_ | 1783558367022678016 |
---|---|
author | Bannister, Aaron Dissanayake, Dushanthi Kowalewski, Antonia Cicon, Leah Bromma, Kyle Chithrani, Devika B. |
author_facet | Bannister, Aaron Dissanayake, Dushanthi Kowalewski, Antonia Cicon, Leah Bromma, Kyle Chithrani, Devika B. |
author_sort | Bannister, Aaron |
collection | PubMed |
description | Nanoparticles (NPs) have shown promise in both radiotherapy and chemotherapy. NPs are mainly transported along cellular microtubules (MTs). Docetaxel (DTX) is a commonly used chemotherapeutic drug that can manipulate the cellular MT network to maximize its clinical benefit. However, the effect of DTX on NP behaviour has not yet been fully elucidated. We used gold NPs of diameters 15 and 50 nm at a concentration of 0.2 nM to investigate the size dependence of NP behaviour. Meanwhile, DTX concentrations of 0, 10 and 50 nM were used to uphold clinical relevance. Our study reveals that a concentration of 50 nM DTX increased NP uptake by ~50% and their retention by ~90% compared to cells treated with 0 and 10 nM DTX. Smaller NPs had a 20-fold higher uptake in cells treated with 50 nM DTX vs. 0 and 10 nM DTX. With the treatment of 50 nm DTX, the cells became more spherical in shape, and NPs were redistributed closer to the nucleus. A significant increase in NP uptake and retention along with their intracellular distribution closer to the nucleus with 50 nM DTX could be exploited to target a higher dose to the most important target, the nucleus in both radiotherapy and chemotherapy. |
format | Online Article Text |
id | pubmed-7355834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73558342020-07-23 Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine Bannister, Aaron Dissanayake, Dushanthi Kowalewski, Antonia Cicon, Leah Bromma, Kyle Chithrani, Devika B. Bioengineering (Basel) Article Nanoparticles (NPs) have shown promise in both radiotherapy and chemotherapy. NPs are mainly transported along cellular microtubules (MTs). Docetaxel (DTX) is a commonly used chemotherapeutic drug that can manipulate the cellular MT network to maximize its clinical benefit. However, the effect of DTX on NP behaviour has not yet been fully elucidated. We used gold NPs of diameters 15 and 50 nm at a concentration of 0.2 nM to investigate the size dependence of NP behaviour. Meanwhile, DTX concentrations of 0, 10 and 50 nM were used to uphold clinical relevance. Our study reveals that a concentration of 50 nM DTX increased NP uptake by ~50% and their retention by ~90% compared to cells treated with 0 and 10 nM DTX. Smaller NPs had a 20-fold higher uptake in cells treated with 50 nM DTX vs. 0 and 10 nM DTX. With the treatment of 50 nm DTX, the cells became more spherical in shape, and NPs were redistributed closer to the nucleus. A significant increase in NP uptake and retention along with their intracellular distribution closer to the nucleus with 50 nM DTX could be exploited to target a higher dose to the most important target, the nucleus in both radiotherapy and chemotherapy. MDPI 2020-06-14 /pmc/articles/PMC7355834/ /pubmed/32545909 http://dx.doi.org/10.3390/bioengineering7020056 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bannister, Aaron Dissanayake, Dushanthi Kowalewski, Antonia Cicon, Leah Bromma, Kyle Chithrani, Devika B. Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title | Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title_full | Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title_fullStr | Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title_full_unstemmed | Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title_short | Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine |
title_sort | modulation of the microtubule network for optimization of nanoparticle dynamics for the advancement of cancer nanomedicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355834/ https://www.ncbi.nlm.nih.gov/pubmed/32545909 http://dx.doi.org/10.3390/bioengineering7020056 |
work_keys_str_mv | AT bannisteraaron modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine AT dissanayakedushanthi modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine AT kowalewskiantonia modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine AT ciconleah modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine AT brommakyle modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine AT chithranidevikab modulationofthemicrotubulenetworkforoptimizationofnanoparticledynamicsfortheadvancementofcancernanomedicine |